A UK government program to address obesity gets major funding from Eli Lilly, the maker of weight loss drug Mounjaro. Critics call it "marketing by another name"
A UK government program to address obesity gets major funding from Eli Lilly, the maker of weight loss drug Mounjaro. Critics call it "marketing by another name"
www.bmj.com
Industry funded NHS obesity programme raises “significant” conflict of interest concerns
